Search results
New Interventional Techniques Eliminate the Need for Thyroid Surgery in Nearly One-Third of Patients with Nodules
… these diseases. It’s not going to be the right treatment for everyone but it is going to be a good treatment for a lot of people.” In this interview, Dr. Kuo discusses … to the parathyroid , and internationally some are using it for adrenal , but that’s probably going to take a while to …
Last Modified:
A pilot study to determine the safety of recovered blood intended for auto- transfusion during pancreatic cancer operations
… of autologous blood transfusions following pancreatectomy for pancreatic ductal adenocarcinoma (PDAC) … study to determine the safety of recovered blood intended for auto- transfusion during pancreatic cancer operations …
Last Modified:
A Multicenter “Ablate and Resect” Study of Novilase Interstitial Laser Therapy for the Ablation of Small Breast Cancers
… to study and report the effects of Novilase breast therapy for small breast cancers. This is a multicenter feasibility … and Resect” Study of Novilase Interstitial Laser Therapy for the Ablation of Small Breast Cancers …
Last Modified:
A Randomized, DoubleBlind, Controlled Evaluation of Tenofovir DF versus Adefovir Dipivoxil for the Treatment of HBeAg Positive Chronic Hepatitis B
… (TDF, tenofovir DF) compared to adefovir dipivoxil (ADV) for the treatment of HBeAg-positive chronic hepatitis B. … Evaluation of Tenofovir DF versus Adefovir Dipivoxil for the Treatment of HBeAg Positive Chronic Hepatitis B …
Last Modified:
Preoperative Extended Chemotherapy Vs Chemotherapy Plus Hypofractionated Radiation Therapy For Borderline Resectable Adenocarcinoma Of The Head Of The Pancreas
… Vs Chemotherapy Plus Hypofractionated Radiation Therapy For Borderline Resectable Adenocarcinoma Of The Head Of The …
Last Modified:
Master regulator analysis to prioritize treatment of residual disease following neoadjuvant chemotherapy for breast cancer in patient-derived tumor xenografts
… of residual disease following neoadjuvant chemotherapy for breast cancer in patient-derived tumor xenografts …
Last Modified:
Phase II Preopertaive Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas
… vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the …
Last Modified:
The Pancreas Center has collaborated with Roche – Genentech for our most recent clinical trial: MORPHEUS a Phase 1b/2 novel pancreatic cancer immunotherapy development platform.
… Pancreatic Center has collaborated with Roche – Genentech for our most recent clinical trial. Roche-Genetech is a … needed to continue developing trustworthy approaches. For example, determining how patients respond to a given … this new platform. For more information about this study, visit https://clinicaltrials.gov/ct2/show/NCT03193190 …
Last Modified:
A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with Chronic Hepatitis C
… The primary objective of this program is to provide DCV for 24 weeks to be given in combination with SOF to subjects … of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with …
Last Modified:
A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
… the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal …
Last Modified:
A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to Treatment in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection
… up study is observational and no treatment is provided for HCV. Trial Website: … A Long Term Follow-up Registry for Subjects Who Achieve a Sustained Virologic Response to …
Last Modified:
Phase I Study of Talimogene Laherparepvec Administered Endoscopically for the Treatment of Locally Advanced or Metastatic Pancreas Cancer Refractory to at Least One Chemotherapy Regimen
… of Talimogene Laherparepvec Administered Endoscopically for the Treatment of Locally Advanced or Metastatic Pancreas …
Last Modified:
A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function.
… The study will consist of a primary study period through 26 weeks and a follow-up period through 52 weeks. Transplant … placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney …
Last Modified:
THRIVE: Thymira Indeterminate FNA Validation: A Validation study to establish the specificity and sensitivity of Thymira diagnostic test for patients with Indeterminate FNAs versus the standard pathological examination
… study of a new molecular diagnostic test, Thymira, for determining malignancy risk in indeterminate nodules. … the specificity and sensitivity of Thymira diagnostic test for patients with Indeterminate FNAs versus the standard …
Last Modified:
Use of Endoscopically Delivered Radiofrequency Ablation for the Treatment of Patients Who Have Undergone Roux-en-Y Gastric Bypass and Have Failed to Achieve/ Maintain Satisfactory Excess Body Weight Loss
… of radiofrequency ablation, delivered via endoscopy, for the treatment of weight regain or inadequate weight loss … not lose at least 40% of their excess weight are eligible for this study. … Use of Endoscopically Delivered Radiofrequency Ablation for the Treatment of Patients Who Have Undergone Roux-en-Y …
Last Modified: